| 发明名称 |
STABLE CANNABINOID FORMULATIONS |
| 摘要 |
The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use. |
| 申请公布号 |
US2016367496(A1) |
申请公布日期 |
2016.12.22 |
| 申请号 |
US201615253010 |
申请日期 |
2016.08.31 |
| 申请人 |
Insys Development Company, Inc. |
发明人 |
Vangara Kiran Kumar;Li Huaguang;Yan Ningxin;Nguyen Hung Q.;Goskonda Venkat R. |
| 分类号 |
A61K31/05;A61K47/26;A61K47/22;A61K47/14;A61K9/00;A61K47/10 |
主分类号 |
A61K31/05 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An oral pharmaceutical formulation comprising cannabidiol and a lipid wherein the formulation provides a cannabidiol pharmacokinetic profile of a mean Cmax of at least 700 (ng/mL) or a mean AUC (0-t) of at least 6000 (h*ng/mL). |
| 地址 |
Chandler AZ US |
